期刊文献+

下胸段食管鳞癌淋巴结标准二野与全二野清扫术的临床比较 被引量:1

A comparison of clinical outcomes between standard and total two-field lymphadenectomy for squamous cell carcinoma of the lower thoracic esophagus
原文传递
导出
摘要 目的探讨适合下胸段食管鳞癌的淋巴结清扫术。方法回顾2004年1月至2007年12月间浙江省肿瘤医院行二野淋巴结清扫术的300例下胸段食管鳞癌患者的临床资料。比较标准二野淋巴清扫术(标准二野组)与全二野淋巴清扫术(全二野组)的临床病理学特点、淋巴结切除情况、术后并发症及生存情况。结果全二野组清扫淋巴结(30±10)枚,多于标准二野组的(26±8)枚(t=3.510,P=0.001)。全二野组出现26例喉返神经损伤,呼吸衰竭率达5.1%,高于标准二野组的0.7%(x。=4.970,P=0.038)。全二野组的5年生存率为28.9%,标准二野组的5年生存率为30.2%,差异无统计学意义(x^2=0.006,P=0.936)。结论全二野淋巴清扫术不提高下胸段食管鳞癌的生存,增加术后并发症。局部晚期的下胸段食管鳞癌需考虑行选择性三野清扫和多学科综合治疗。 Objective To explore the suitable lymphadenectomy for squamous cell carcinoma of the lower thoracic esophagus. Methods From January 2004 to December 2007, 300 patients with lower thoracic esophageal squamous cell carcinoma underwent Ivor-Lewis esophagectomy with 2-field lymphadenectomy in our department. All cases were retrospectively analyzed. 143 cases underwent standardlymphadenectomy (standard group), 157 cases underwent total lymphadenectomy( total group). The clinical and pathological characteristics, the status of lymph node metastases, postoperative complications and survival rates were compared between two groups. Results There were more lymph nodes dissected ( 30 ±10 vs 26 ±8, P =0. 001 ) and higher respiratory failure rate ( 16. 6% vs 0. 7% , P = 0. 038 ) in total group than in standard group. The 5-year survival rate was 28.9% and 30. 2%, respectively(P =0. 936). Conclusion The total 2-field lymphadenectomydoesn't provides better survival benefit for patients with squamous cell carcinoma of the lower thoracic esophagus, instead more complications occurred. For local advanced tumor, 3-field lymphadenectomy and comprehensive treatment should be considered.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第41期3297-3299,共3页 National Medical Journal of China
关键词 食管肿瘤 鳞状细胞 淋巴结切除术 Esophageal neoplasms Carcinoma, squamous cell Lymph node excision
  • 相关文献

参考文献12

二级参考文献51

  • 1Ando N, Iizuka T, Kakegawa T, et al. Randomized trial of surgery with and without chemotherapy for localized squamous carcinoma of the thoracic esophagus: the Japan Clinical Oncology Group study. J Thorac Cardiovasc Surg, 1997,114:205-209.
  • 2Earlam R, Cunha-Melo JR. Oesophageal squamous cell carcinoma I: acritical review of surgery. Br J Surg,1980,67:381-390.
  • 3Muller JM, Erasmi H, Stelzen M, et al. Surgical therapy of oesophageal carcinoma. Br J Surg,1990,77:845-857.
  • 4Zhang DW, Cheng GY, Huang GJ, et al. Operable squamous esophageal carcinoma: current results from the East. World J Surg,1994,18:347-354.
  • 5Watson A. Operable squamous esophageal carcinoma: current results from the West. World J Surg,1994,18:361-366.
  • 6Fang W, Kato H, Chen W, et al. Comparison of surgical management of thoracic esophageal carcinoma between two referral centers in Japan and China. Jpn J Clin Oncol, 2001,31:203-208.
  • 7Shields TW. Lymphatic drainage of the esophagus. In: General thoracic surgery. 3rd ed. Baltimore: Williams & Wilkins,1994.1370-1377.
  • 8Kato H, Tachimori Y, Watanabe H, et al. Lymph node metastasis in thoracic esophageal carcinoma. J Surg Oncol,1991,48:106-111.
  • 9Isono K, Sato H, Nakayama K. Results of a nationwide study on three-field lymph node dissection of esophageal cancer. Oncology, 1991,48:411-420.
  • 10Kato H, Tachimori Y, Watanabe H, et al. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection. J Surg Oncol,1996,61:267-272.

共引文献177

同被引文献10

  • 1Parkin MD, Bray F, Ferlay J, et al. Global cancer statistics, 2002[J]. Cancer J Clin, 2005,55 (2) : 74-108.
  • 2Zhang XM, Guo MZ. The value of epigenetic markers in esophageal cancer front[J]. Med China, 2010,4 (4):378- 384.
  • 3刘俊峰,王义舫,高杨,等.食管鳞状细胞癌淋巴结转移与预后的关系[C].//中国第九届全国食管癌学术会议,2009,109-202.
  • 4Hu Y,Hu C,Zhang H,et al. How does the number of re- sected lymph nodes inpluence TNM staging and prognosis for esophageal carcinoma? [J]. Ann Surg Oncol, 2010,17 (3) :784-790.
  • 5Chen J,Liu S,Pan J, et al. The pattern and prevalence of lymphatic spread in thoracic oesophageal squamous cell carcinoma[J]. Eur J Cardiothorac Surg, 2009,36 (3) : 480- 486.
  • 6Law S,Wong J. Two-field dissection is enough for esoph- ageal cancer[J]. Dis Esophagus, 2011,14 : 98-103.
  • 7Watanabe H, Kato H, Tachimori Y. Significance of ex- tended systemic lymphnode dissection for thoracic esoph- ageal caicinoma in Japan[J]. Recent Results Cancer Res, 2000,155(2) :123-133.
  • 8H uang W, Li B, Gong H, et al. Pattern of lymph node me- tastases and its implication in radiotherapeutic clinical tar- get volume in patients with thoracic esophageal squamous cell carcinoma., a report of 1 077 cases[J]. Radiother On- coi,2010,95(2) :229-233.
  • 9汪永和,魏祥志,岳庆峰,张科,孙永刚,江陈.中段食管癌根治术扩大二野清扫淋巴结的临床体会[J].安徽医学,2013,34(1):31-33. 被引量:8
  • 10葛新国,周立莉,张爱江,严广,黄志华,陈旭东,刘志勇.食管鳞癌患者三野淋巴结清扫术与二野淋巴结清扫术临床效果的对比研究[J].中国医药指南,2014,12(31):39-40. 被引量:4

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部